Insider · CIK 0001181153

COVINGTON PAUL S

Reports to the SEC for 2 companies · MORRISVILLE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001181153

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-07-02	Furiex Pharmaceuticals, Inc.D Disposition to Issuer	Senior VP-Clinical Operations	DDisposition to Issuer	−22.5K sh	—	—	0
2014-07-02	Furiex Pharmaceuticals, Inc.Stock Options (to buy)D Disposition to Issuer	Senior VP-Clinical Operations	DDisposition to Issuer	−26K sh	—	—	0
2014-07-02	Furiex Pharmaceuticals, Inc.Stock Options (to buy)D Disposition to Issuer	Senior VP-Clinical Operations	DDisposition to Issuer	−37.9K sh	—	—	0
2014-02-28	Furiex Pharmaceuticals, Inc.A Award	Senior VP-Clinical Operations	AAward	+13.5K sh	—	—	28,623
2013-09-10	Furiex Pharmaceuticals, Inc.M Exercise/Conversion	Senior VP-Clinical Operations	MExercise/Conversion	+30K sh	$9.11	+$273K	45,123
2013-09-10	Furiex Pharmaceuticals, Inc.Stock Options (to buy)M Exercise/Conversion	Senior VP-Clinical Operations	MExercise/Conversion	−30K sh	—	—	45,691
2013-09-10	Furiex Pharmaceuticals, Inc.S Sale	Senior VP-Clinical Operations	SSale	−30K sh	$40.89	−$1.23M	15,123
2013-06-10	Furiex Pharmaceuticals, Inc.A Award	Senior VP-Clinical Operations	AAward	+12.2K sh	—	—	15,123
2012-02-24	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Senior VP-Clinical Operations	AAward	+10.4K sh	—	—	10,368
2011-12-05	Furiex Pharmaceuticals, Inc.P Purchase	Senior VP-Clinical Operations	PPurchase	+2,850 sh	$17.68	+$50.4K	2,923
2011-10-03	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Senior VP-Clinical Operations	AAward	+37.9K sh	—	—	37,944
2011-05-09	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Senior VP-Clinical Operations	AAward	+26K sh	—	—	26,000
2010-06-17	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Senior VP-Clinical Operations	AAward	+75.7K sh	—	—	75,691
2008-06-30	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCI Discretionary Transaction	Executive Vice President	IDiscretionary Transaction	+619 sh	$36.33	+$22.5K	881
2007-12-31	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCI Discretionary Transaction	Executive Vice President	IDiscretionary Transaction	+262 sh	$34.44	+$9,023.28	262
2007-12-17	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock options (to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−20K sh	—	—	—
2007-08-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−9,045 sh	$35.09	−$317K	0
2007-06-30	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCI Discretionary Transaction	Executive Vice President	IDiscretionary Transaction	+261 sh	$29.00	+$7,569	9,042
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−700 sh	$35.14	−$24.6K	9,831
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−25K sh	—	—	50,000
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−13.3K sh	—	—	0
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−2,600 sh	$35.26	−$91.7K	8,781
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−1,200 sh	$35.28	−$42.3K	11,381
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−2,800 sh	$35.27	−$98.8K	12,581
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−2,800 sh	$35.24	−$98.7K	15,381
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−2,800 sh	$35.23	−$98.6K	18,181
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−2,800 sh	$35.21	−$98.6K	20,981
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−10K sh	$35.20	−$352K	23,781
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−13.3K sh	$35.11	−$468K	33,781
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Executive Vice President	MExercise/Conversion	+25K sh	$21.19	+$530K	47,115
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Executive Vice President	MExercise/Conversion	+13.3K sh	$15.30	+$204K	22,115
2007-05-29	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−1,050 sh	$35.13	−$36.9K	8,781
2006-06-30	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCI Discretionary Transaction	Executive Vice President	IDiscretionary Transaction	+313 sh	$27.87	+$8,723.31	10,219
2005-12-31	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCI Discretionary Transaction	Executive Vice President	IDiscretionary Transaction	+77 sh	$40.12	+$3,089.24	4,953
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−15K sh	—	—	85,001
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−200 sh	$54.65	−$10.9K	34,676
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−1,900 sh	$54.66	−$104K	32,776
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−2,900 sh	$54.67	−$159K	29,876
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−9,900 sh	$55.32	−$548K	19,976
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−100 sh	$55.33	−$5,533	19,876
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−3,407 sh	$54.75	−$187K	16,469
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−1,100 sh	$54.76	−$60.2K	15,369
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−493 sh	$54.77	−$27K	14,876
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−9,253 sh	$55.40	−$513K	5,623
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−747 sh	$55.42	−$41.4K	4,876
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−20K sh	—	—	100,001
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−485 sh	$55.04	−$26.7K	34,876
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−15K sh	—	—	70,001
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−700 sh	$55.03	−$38.5K	35,361
2005-08-23	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Executive Vice President	SSale	−715 sh	$55.01	−$39.3K	36,061

Recent filings

Accepted (ET)
Jul 74
Furiex Pharmaceuticals, Inc.0001437749-14-012510
SEC(opens sec.gov)
Mar 44
Furiex Pharmaceuticals, Inc.0001437749-14-003386
SEC(opens sec.gov)
Sep 124
Furiex Pharmaceuticals, Inc.0001437749-13-011939
SEC(opens sec.gov)
Jun 124
Furiex Pharmaceuticals, Inc.0001437749-13-007533
SEC(opens sec.gov)
Apr 114
Furiex Pharmaceuticals, Inc.0001181431-12-023705
SEC(opens sec.gov)
Dec 74
Furiex Pharmaceuticals, Inc.0001181431-11-059292
SEC(opens sec.gov)
Oct 54
Furiex Pharmaceuticals, Inc.0001181431-11-051848
SEC(opens sec.gov)
May 114
Furiex Pharmaceuticals, Inc.0001181431-11-028870
SEC(opens sec.gov)
Jun 214
Furiex Pharmaceuticals, Inc.0001181431-10-034127
SEC(opens sec.gov)
Jul 84
PHARMACEUTICAL PRODUCT DEVELOPMENT INC0001181153-08-000005
SEC(opens sec.gov)
Jan 44
PHARMACEUTICAL PRODUCT DEVELOPMENT INC0001181153-08-000001
SEC(opens sec.gov)
Aug 294
PHARMACEUTICAL PRODUCT DEVELOPMENT INC0001181153-07-000006
SEC(opens sec.gov)
Jul 54
PHARMACEUTICAL PRODUCT DEVELOPMENT INC0001181153-07-000005
SEC(opens sec.gov)
May 304
PHARMACEUTICAL PRODUCT DEVELOPMENT INC0001181153-07-000003
SEC(opens sec.gov)

Companies

Address

C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150

MORRISVILLE, NC, 27560